Richards Jeff G, Bonen Arend, Heigenhauser George J F, Wood Chris M
Department of Zoology, McMaster University, Hamilton, Ontario, Canada L8S 4K1.
Am J Physiol Regul Integr Comp Physiol. 2004 Jan;286(1):R46-53. doi: 10.1152/ajpregu.00319.2003. Epub 2003 Sep 11.
We examined the movement of [3H]palmitate across giant sarcolemmal vesicles prepared from red and white muscle of rainbow trout (Oncorhynchus mykiss). Red and white muscle fatty acid carriers have similar affinities for palmitate (apparent Km = 26 +/- 6 and 33 +/- 8 nM, respectively); however, red muscle has a higher maximal uptake compared with white muscle (Vmax = 476 +/- 41 vs. 229 +/- 23 pmol.mg protein-1.s-1, respectively). Phloretin (250 microM) inhibited palmitate influx in red and white muscle vesicles by approximately 40%, HgCl2 (2.5 mM) inhibited palmitate uptake by 20-30%, and the anion-exchange inhibitor DIDS (250 microM) inhibited palmitate influx in red and white muscle vesicles by approximately 15 and 30%, respectively. Western blot analysis of red and white muscle vesicles did not detect a mammalian-type fatty acid transporter (FAT); however, preincubation of vesicles with sulfo-N-succinimidyloleate, a specific inhibitor of FAT in rats, reduced palmitate uptake in red and white muscle vesicles by approximately 15 and 25%, respectively. A mammalian-type plasma membrane fatty acid-binding protein was identified in trout muscle using Western blotting, but the protein differed in size between red and white muscle. At low concentrations of free palmitate (2.5 nM), addition of high concentrations (111 microM total) of oleate (18:0) caused approximately 50% reduction in palmitate uptake by red and white muscle vesicles, but high concentrations (100 microM) of octanoate (8:0) caused no inhibition of uptake. Five days of aerobic swimming at approximately 2 body lengths/s and 9 days of chronic cortisol elevation in vivo, both of which stimulate lipid metabolism, had no effect on the rate of palmitate movement in red or white muscle vesicles.
我们研究了[3H]棕榈酸酯跨越大西洋鲑(Oncorhynchus mykiss)红肌和白肌制备的巨大肌膜囊泡的转运情况。红肌和白肌脂肪酸载体对棕榈酸酯的亲和力相似(表观Km分别为26±6和33±8 nM);然而,与白肌相比,红肌具有更高的最大摄取量(Vmax分别为476±41和229±23 pmol·mg蛋白-1·s-1)。根皮素(250 μM)抑制红肌和白肌囊泡中棕榈酸酯的流入约40%,HgCl2(2.5 mM)抑制棕榈酸酯摄取20 - 30%,阴离子交换抑制剂DIDS(250 μM)分别抑制红肌和白肌囊泡中棕榈酸酯的流入约15%和30%。对红肌和白肌囊泡进行蛋白质免疫印迹分析未检测到哺乳动物型脂肪酸转运蛋白(FAT);然而,用大鼠FAT的特异性抑制剂磺基-N-琥珀酰亚胺油酸酯对囊泡进行预孵育,分别使红肌和白肌囊泡中棕榈酸酯的摄取减少约15%和25%。通过蛋白质免疫印迹在鲑鱼肌肉中鉴定出一种哺乳动物型质膜脂肪酸结合蛋白,但该蛋白在红肌和白肌中的大小不同。在游离棕榈酸酯浓度较低(2.5 nM)时,添加高浓度(总浓度111 μM)的油酸(18:0)使红肌和白肌囊泡中棕榈酸酯的摄取减少约50%,但高浓度(100 μM)的辛酸(8:0)对摄取无抑制作用。在体内以约2体长/秒的速度进行5天有氧游泳以及9天慢性皮质醇升高,这两种情况均刺激脂质代谢,但对红肌或白肌囊泡中棕榈酸酯的转运速率均无影响。